Utah Medical Cannabis 2022 Refresher Training - Clinical Considerations

Thursday, September 1, 2022, 8:30 AM - Monday, September 30, 2024, 10:30 AM


AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation AMA PRA Category 1 Credits™ (2.00 hours), ACPE Contact Hour(s) (2.00 hours)

Release Date: September 1, 2022 / Expiration Date: September 30, 2024

This activity is intended for prescribers, pharmacists, legal counsel and other allied health professionals who have an interest in the Utah Medical Cannabis Law and how it will impact them. This activity will fulfill the qualified medical provider renewal education requirement from the state of Utah.

Instructions on how to complete course:

• Go to the "Resources & Tests" tab
• Complete the pre-tests prior to each section
• Watch the video recordings and read attached documentation
• Complete the post-tests associated with the recorded videos with a score of 75% or better  (You will have 2 attempts to pass each test)
• Once all post-tests have been passed, fill out the evaluation found in your "My CE" area under the "Evaluations & Certificates" area.
• Credit should then be automatically awarded on your transcript

Disclosure: None of the speaker(s), planner(s), or anyone in control of this educational content have any relevant financial relationships to disclosure.

Acknowledgment of Commercial Support: No commercial support is being received for this activity.

System Requirements:

• Operating Systems: Any operating system that supports modern web browsers that adhere to the WC III standards.
  
• Browsers: For best performance and compatibility, we recommend using the latest version of Firefox or Chrome. The CloudCME® administration system will run in Internet Explorer, Safari and the iOS browser though performance and display of some items may vary.
  
• Cookies: Cookies must be enabled in your browser to allow the system to operate. Cookies are not used to store any personal information, but are used by the program for basic screen management operations.
  
• JavaScript: JavaScript must be enabled in your browser to allow the system to operate. The only time JavaScript would not be enabled is if you work in an environment where the IT department has disabled JavaScript
  
• Security: Setting the browser security to Medium High or High may disable certain operations in CloudCME®. Browser security should be set to the default, standard settings.
  
• Screen Resolution: A minimum resolution of 1024x768 can be used, but due to the large amount of data on many screens the highest resolution available on your system will provide more usable space and make using CloudCME® more efficient.
  
  

Confidentiality Policy: Confidentiality Policy.pdf
Please contact [email protected] or 801-507-8470 with questions.

The following activities are approved for ACPE credit:

• Medical Cannabis Clinical Updates and Review of Cyclic Vomiting - ACPE UAN 0582-0000-22-078-H01-P (1.0 hours or 0.1 CEUs, application-based disease state management / drug therapy)
  
  • Compare available medical cannabis formulation allowed in the State of Utah and differentiate between tetrahydrocannabidiol (THC) and cannabidiol (CBD) effects.
    
  • Use available medical cannabis resources for providers and patients regarding work related use of cannabis.
    
  • Evaluate available literature for cannabis use in cyclic vomiting syndrome.
    
• Medical Cannabis in Psychiatry: Therapeutic Benefits and Adverse Effects - ACPE UAN 0582-0000-22-079-H01-P (1.0 hours or 0.1 CEUs, application-based disease state management / drug therapy)
  
  • Compare and contrast the pharmacologic profiles of key cannabinoids found in medical cannabis.
    
  • Summarize evidence supporting or discouraging medical cannabis use in psychiatry.
    
  • Appraise the appropriateness of medical cannabis use for psychiatric conditions given current limitations in published literature.
    
  • Explain neuropsychiatric adverse effects neurol associated with acute and chronic medical cannabis use.

1. Summarize and describe key details of the Utah Medical Cannabis Act
2. Compare available formulation allowed in the State of Utah and differentiate between tetrahydrocannabidiol (THC) and cannabidiol (CBD)
3. Review available literature for cannabis use in various qualifying conditions included in the Utah Medical Cannabis Act
4. Describe the risks and benefits of medical cannabis use in special populations
5. Discuss available medical cannabis resources for providers and patients

Intermountain Healthcare is accredited by the Accreditation Council for Continuing Medical Education (ACCME)  to provide continuing medical education for physicians. 

Intermountain Healthcare designates this enduring material for 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Accreditation for this educational program is provided by Intermountain Healthcare. Intermountain Healthcare is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. To receive credit, attendees must complete a post-test with a score of 75% or better and complete an activity evaluation for each activity. All credit will be reported directly to CPE Monitor™ within 60 days of claiming credit. Intermountain is not responsible for credit report failure as a result of incorrect NABP or date of birth information. 

Mitigation of Relevant Financial Relationships

Intermountain Healthcare - Interprofessional Continuing Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.